According to a new report, published by KBV research, The Global Diabetic Foot Ulcer Treatment Market size is expected to reach $6.5 billion by 2030, rising at a market growth of 5.2% CAGR during the forecast period.
The Wound Care Devices segment would witness a CAGR of 5.5% during (2023 - 2030). This is because extracorporeal shock wave treatment for wound care has been adopted, along with negative pressure wound therapy and other innovative therapies. New wound care devices are expected to become more popular throughout the projection period because of their distinct benefits in exudate control, speed-up wound healing, and relatively lower care costs for wound management.
The Neuro ischemic Ulcers segment is leading the Global Diabetic Foot Ulcer Treatment Market by Type in 2022; thereby, achieving a market value of $3.1 billion by 2030. People who suffer from peripheral neuropathy, as well as ischemia brought on by peripheral artery disease, get these foot ulcers. Without treatment, neuro ischemic ulcers are very unlikely to heal, and if they become infected, there is a high chance of amputation.
The Hospitals segment is experiencing a CAGR of 5.4% during (2023 - 2030). Under such conditions, hospitals become the primary location that a patient first visits, making them the largest market within this sector. Such large and complicated ulcers can be managed only in a hospital setting with all the additional amenities available. To appropriately treat and promote healing of a diabetic foot ulcer, qualified medical personnel are necessary.
The North America region dominated the Global Diabetic Foot Ulcer Treatment Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2.4 billion by 2030. The Asia Pacific market is poised to grow at a CAGR of 5.9% during (2023 - 2030). Additionally, The Europe market is expected to witness a CAGR of 5% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/diabetic-foot-ulcer-treatment-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Coloplast Group, B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Smith & Nephew PLC, Cardinal Health, Inc., Medtronic PLC, 3M Company, Molnlycke Health Care AB, Essity AB and ConvaTec Group PLC.
By Product
By Type
By End User
By Geography
Companies Profiled
Unique Offerings 
